TCRX Latest Press Releases

-- September 2, 2026 --

TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors Globe Newswire 7:00 AM

-- August 12, 2026 --

TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- July 29, 2026 --

TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2 , a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies Globe Newswire 7:00 AM

-- June 24, 2026 --

TScan Therapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference Globe Newswire 7:00 AM

-- June 22, 2026 --

TScan Therapeutics Announces Positive Initial Data from Cohort C of Ongoing ALLOHA Phase 1 Study Evaluating TSC-101 in Patients with Heme Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes